
News











Speakers at DIA's 45th Annual Meeting discuss indepth the stumbling blocks of informed consent and potential solutions that may clear the way.

Don't miss the pressing topics in the biotechnology industry that presenters discussed this year at DIA's 45th Annual Meeting.

San Diego Convention Center welcomes a packed house, as U.S. meeting gets underway with California casualness.



GCP in China is coming along, but much more is needed.







Global Head, Data Management, Bayer Schering Pharma AG, Germany, offers his perspective on recent trends in data management and why it's important to keep it in-house.

Beth Harper, MBA, president, Clinical Performance Partners, offers Site Relationship Management initiative insights from the past year.
Applied Clinical Trials spoke with President-elect, DIA Board of Directors; Jeff Sherman, MD, FACP about the Association, the 45th Annual Meeting, and upcoming DIA initiatives.



Marie A. Dray, MBA, President, DIA Board of Directors; and President, International Regulatory Affairs Group LLC offered the opening remarks to a limited gathering of invitees to the DIA's second Executive Roundtable focused on biotech issues.


Podcasts:DIA-Nancy D. Smith